StockData
Moleculin Biotech, Inc. logo

Moleculin Biotech, Inc. (MBRX) stock

MBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$7.87−0.19 (-2.36%)

Close on Nov 13, 2026Market cap $8.23MP/E –Yield –

Moleculin Biotech statistics

60 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$8.23M
$272.32M
Enterprise Value
$941.45K
$146.23M
PB Ratio
0.57
2.00
P/TBV Ratio
0.57
2.22

Share statisticsIndustry

Shares Change (YoY)
907.2%
10.8%
Shares Change (QoQ)
-85.3%
0.50%
Shares Held by Institutions
0.89%
56.4%

Short sellingIndustry

Short Interest
54,541
–
Short Interest Change
-56.8%
-0.80%
Short % of Shares Outstanding
5.22%
6.30%
Days to Cover
1.00
5.15

Stock price statisticsIndustry

52-Week High
$243.80
–
52-Week Low
$3.23
–
20-Day Moving Average
$7.76
–
50-Day Moving Average
$9.94
–
200-Day Moving Average
$36.32
–
Average True Range (14)
$0.93
–
Price Change (1 Week)
-9.54%
-1.15%
Price Change (1 Month)
6.32%
-4.87%
Price Change (3 Months)
-35.2%
-21.0%
Price Change (6 Months)
-81.4%
-20.6%
Price Change (YTD)
-88.1%
-23.6%
Price Change (1 Year)
-96.8%
-22.4%
Price Change (3 Years)
-99.8%
-29.5%
Price Change (5 Years)
-100.0%
-77.9%
Price Change (10 Years)
-100.0%
-65.4%
Average Volume (10 Days)
18,302
–
Average Volume (20 Days)
43,939
–
Average Volume (90 Days)
56,907
–
Relative Volume
0.17
0.70
Relative Strength Index (14)
43.6
43.4
Volatility (1 Year)
136.8%
80.1%
Beta (5 Years)
1.17
1.07

Returns on capitalIndustry

Return on Assets (ROA)
-55.6%
-40.6%
Return on Capital Employed (ROCE)
-202.6%
-37.9%

Financial positionIndustry

Current Ratio
1.37
3.30
Quick Ratio
1.19
2.39

EfficiencyIndustry

Asset Turnover
0.00
0.40
Revenue Per Employee
$0
$429.29K
Profits Per Employee
-$76
-$689.41K
Employee Count
150,000
74
WACC
10.9%
10.2%

Income statement (TTM)Industry

Revenue
$0
$66.37M
Operating Income
-$29.58M
-$21.37M
Net Income
-$11.42M
-$22.35M
EBITDA
-$29.55M
-$17.21M
EPS (Diluted)
-$7.63
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$7.29M
$17.76M
Net Cash Per Share
$6.97
$0.80
Equity (Book Value)
$14.49M
$53.89M
Book Value Per Share
$13.86
$1.50
Tangible Book Value
$14.49M
$27.13M
Working Capital
$2.28M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$27.10M
-$12.38M

Dividends and yieldsIndustry

Earnings Yield
-138.8%
-21.8%

Taxes and interestIndustry

Income Tax
$0
$73.00K

Scores and fair valueIndustry

Altman Z-Score
-19.51
0.23
Piotroski F-Score
3
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodMBRXS&P 500DifferenceMBRX per yearS&P 500 per year
1 month-9.6%-3.0%−6.5 pts
3 months-31.1%-2.8%−28.3 pts
Year to date-88.1%+11.5%−99.6 pts
1 year-96.5%+13.5%−110.0 pts
3 years-99.8%+77.7%−177.5 pts-87.8%+21.1%
5 years-100.0%+72.6%−172.6 pts-78.8%+11.5%
10 years-100.0%+308.2%−408.2 pts-62.0%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M MBRX shares were sold short on Oct 30, 2026, down 56.8% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 44.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202654,541-56.8%67,6461.0
Oct 15, 2026126,324-38.3%354,2711.0
Sep 30, 2026204,583-28.9%1,712,3921.0
Sep 15, 2026287,608+61.5%652,8991.0
Aug 31, 2026178,126-43.7%691,1141.0
Aug 14, 2026316,392-79.9%2,216,1811.0
Jul 31, 20261,577,365+49.6%1,913,8361.0
Jul 15, 20261,054,620-25.4%246,9064.3
Jun 30, 20261,413,550+22.4%1,882,3771.0
Jun 15, 20261,154,952+39.3%228,1525.1
May 29, 2026828,958+57.1%263,3223.1
May 15, 2026527,786+57.8%249,1002.1

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?